Migreen kliinilised uuringud osariigis Michigan
6 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Michigan.
Linnad osariigis Michigan
Ametlik uuringutekst (inglise keeles)
Study of EVO756 in Adults With Migraine
- Michigan Headache and Neurological Institute, Ann Arbor
- Quest Research Institute-Alcanza, Farmington Hills
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NRST - Detroit, Detroit
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 28. sept 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Michigan Head Pain and Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- ja veel 1
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Michigan Head Pain & Neurological Institute, Ann Arbor
- Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
- Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
- ja veel 1
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT06810505A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Michigan Headache Pain & Neurological Institute, Ann Arbor
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.